Riot Platforms, Inc. — Director's Dealing 2012

May 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-05-23

Reporting Person: Hurd Donald R (SVP, Chief Commerical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-23	Stock Option (Right to Buy)	$0.57	A	120000	Acquired	2022-05-23	Common Stock (120000)	Direct

Footnotes

F1: The option to purchase 120,000 shares of common stock shall become exercisable as to 50% of the shares on November 23, 2012, as to 8.33% of the shares on each of December 23, 2012, January 23, 2013, February 23, 2013, and March 23, 2013, and as to 8.34% of the shares on each of April 23, 2013 and May 23, 2013.